|
US9694084B2
(en)
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
JP6815318B2
(ja)
|
2014-12-23 |
2021-01-20 |
ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド |
二官能性分子によって標的化タンパク質分解を誘導する方法
|
|
US12312316B2
(en)
|
2015-01-20 |
2025-05-27 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of androgen receptor
|
|
JP7269731B2
(ja)
|
2015-03-18 |
2023-05-09 |
アルビナス・オペレーションズ・インコーポレイテッド |
標的タンパク質の分解向上のための化合物および方法
|
|
WO2016197114A1
(en)
|
2015-06-05 |
2016-12-08 |
Arvinas, Inc. |
Tank-binding kinase-1 protacs and associated methods of use
|
|
WO2017007612A1
(en)
|
2015-07-07 |
2017-01-12 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
CN108137507A
(zh)
|
2015-07-10 |
2018-06-08 |
阿尔维纳斯股份有限公司 |
基于mdm2的蛋白水解调节剂和相关的使用方法
|
|
US20170281784A1
(en)
|
2016-04-05 |
2017-10-05 |
Arvinas, Inc. |
Protein-protein interaction inducing technology
|
|
AU2017254702B2
(en)
*
|
2016-04-22 |
2020-12-24 |
Dana-Farber Cancer Institute, Inc. |
Degradation of cyclin-dependent kinase 9 (CDK9) by conjugation of CDK9 inhibitors with E3 ligase ligand and methods of use
|
|
EP3892272B1
(en)
|
2016-04-22 |
2024-07-24 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional molecules for degradation of egfr and methods of use
|
|
ES2975558T3
(es)
|
2016-09-15 |
2024-07-09 |
Arvinas Inc |
Derivados de indol como degradantes de receptor de estrógeno
|
|
WO2018064589A1
(en)
|
2016-09-29 |
2018-04-05 |
Dana-Farber Cancer Institute, Inc. |
Targeted protein degradation using a mutant e3 ubiquitin ligase
|
|
EP3535265A4
(en)
*
|
2016-11-01 |
2020-07-08 |
Arvinas, Inc. |
PROTACS TARGETING ON TAU PROTEIN AND RELATED METHODS FOR USE
|
|
WO2018102725A1
(en)
|
2016-12-01 |
2018-06-07 |
Arvinas, Inc. |
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
|
|
EP3559006A4
(en)
|
2016-12-23 |
2021-03-03 |
Arvinas Operations, Inc. |
COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF F TAL LIVER KINASE POLYPEPTIDES
|
|
RU2019121527A
(ru)
*
|
2016-12-23 |
2021-01-15 |
Эрвинэс Оперейшнс, Инк. |
Химерные молекулы, нацеливающиеся на протеолиз egfr, и связанные с ними способы применения
|
|
EP3558994A4
(en)
|
2016-12-23 |
2021-05-12 |
Arvinas Operations, Inc. |
COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF FAST ACCELERATED FIBROSARCOMA POLYPEPTIDES
|
|
US11173211B2
(en)
|
2016-12-23 |
2021-11-16 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of rapidly accelerated Fibrosarcoma polypeptides
|
|
US11191741B2
(en)
|
2016-12-24 |
2021-12-07 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
|
|
MX2019008934A
(es)
|
2017-01-26 |
2019-11-05 |
Arvinas Operations Inc |
Moduladores de la proteolisis del receptor de estrogeno y métodos asociados de uso,.
|
|
EP3577109A4
(en)
|
2017-01-31 |
2020-11-18 |
Arvinas Operations, Inc. |
CEREMONY LIGANDS AND BIFUNCTIONAL COMPOUNDS CONTAINING THEM
|
|
US12023385B2
(en)
|
2017-02-08 |
2024-07-02 |
Dana-Farber Cancer Institute, Inc. |
Tunable endogenous protein degradation with heterobifunctional compounds
|
|
US11065231B2
(en)
|
2017-11-17 |
2021-07-20 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptides
|
|
JP2021506848A
(ja)
|
2017-12-18 |
2021-02-22 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
Ｅ３ユビキチンリガーゼ部分を持つｅｇｆｒを有する二官能性阻害剤
|
|
JP2021512059A
(ja)
|
2018-01-29 |
2021-05-13 |
ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド |
ブルトン型チロシンキナーゼ（ｂｔｋ）阻害剤のｅ３リガーゼリガンドとのコンジュゲーションによるｂｔｋの分解および使用方法
|
|
TW201945357A
(zh)
|
2018-02-05 |
2019-12-01 |
瑞士商赫孚孟拉羅股份公司 |
化合物
|
|
CA3090275A1
(en)
|
2018-02-14 |
2019-08-22 |
Dana-Farber Cancer Institute, Inc. |
Irak degraders and uses thereof
|
|
CA3088972A1
(en)
*
|
2018-02-20 |
2019-08-29 |
Dana-Farber Cancer Institute, Inc. |
Pharmaceutical combinations of egfr inhibitors and methods of use thereof
|
|
WO2019183523A1
(en)
*
|
2018-03-23 |
2019-09-26 |
Genentech, Inc. |
Hetero-bifunctional degrader compounds and their use as modulators of targeted ubiquination (vhl)
|
|
US12539292B2
(en)
|
2018-04-01 |
2026-02-03 |
Arvinas Operations, Inc. |
BRM targeting compounds and associated methods of use
|
|
CN119569702A
(zh)
|
2018-04-04 |
2025-03-07 |
阿尔维纳斯运营股份有限公司 |
蛋白水解调节剂及相关使用方法
|
|
CN108610332B
(zh)
*
|
2018-06-08 |
2020-04-03 |
绍兴文理学院 |
诱导MDM2自我降解E3泛素连接酶二聚体酯类小分子PROTACs
|
|
CN108610333B
(zh)
*
|
2018-06-08 |
2020-04-03 |
绍兴文理学院 |
诱导MDM2自我降解E3泛素连接酶二聚体酰胺类小分子PROTACs
|
|
WO2019241231A1
(en)
*
|
2018-06-11 |
2019-12-19 |
Abhishek Sharma |
Antiestrogen compounds
|
|
CN112533898A
(zh)
|
2018-07-31 |
2021-03-19 |
日商泛美克斯股份有限公司 |
杂环化合物
|
|
US11707452B2
(en)
|
2018-08-20 |
2023-07-25 |
Arvinas Operations, Inc. |
Modulators of alpha-synuclein proteolysis and associated methods of use
|
|
US20210338825A1
(en)
*
|
2018-09-28 |
2021-11-04 |
Dana-Farber Cancer Institute, Inc. |
Degraders of hepatitis c virus ns3/4a protein
|
|
CN113423701A
(zh)
|
2018-11-13 |
2021-09-21 |
拜欧斯瑞克斯公司 |
取代的异吲哚啉酮
|
|
US12582641B2
(en)
|
2019-02-25 |
2026-03-24 |
Shanghaitech University |
Sulfur-containing compound based on glutarimide skeleton and application thereof
|
|
CA3133314A1
(en)
|
2019-03-21 |
2020-09-24 |
Codiak Biosciences, Inc. |
Extracellular vesicle conjugates and uses thereof
|
|
US12233356B2
(en)
|
2019-03-21 |
2025-02-25 |
Lonza Sales Ag |
Process for preparing extracellular vesicles
|
|
MA55628A
(fr)
|
2019-04-12 |
2022-02-16 |
C4 Therapeutics Inc |
Agents de dégradation tricycliques d'ikaros et d'aiolos
|
|
CN110204532B
(zh)
*
|
2019-05-15 |
2022-03-08 |
浙江工业大学 |
一种靶向egfr蛋白降解的化合物及其制备方法和应用
|
|
WO2020257607A1
(en)
|
2019-06-21 |
2020-12-24 |
Dana-Farber Cancer Institute, Inc. |
Allosteric egfr inhibitors and methods of use thereof
|
|
WO2021011913A1
(en)
|
2019-07-17 |
2021-01-21 |
Arvinas Operations, Inc. |
Tau-protein targeting compounds and associated methods of use
|
|
CN112321566B
(zh)
*
|
2019-08-05 |
2022-06-10 |
上海科技大学 |
Egfr蛋白降解剂及其抗肿瘤应用
|
|
ES3061133T3
(en)
|
2019-08-26 |
2026-03-31 |
Arvinas Operations Inc |
Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders
|
|
US12310975B2
(en)
|
2019-10-17 |
2025-05-27 |
Arvinas Operations, Inc. |
Modulators of BCL6 proteolysis and associated methods of use
|
|
WO2021121261A1
(zh)
*
|
2019-12-16 |
2021-06-24 |
北京泰德制药股份有限公司 |
抑制并诱导降解egfr激酶的化合物
|
|
EP4077309A1
(en)
|
2019-12-19 |
2022-10-26 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of androgen receptor
|
|
EP4681715A3
(en)
|
2019-12-20 |
2026-01-28 |
C4 Therapeutics, Inc. |
Isoindolinone and indazole compounds for the degradation of egfr
|
|
WO2021152113A1
(en)
*
|
2020-01-31 |
2021-08-05 |
Bayer Aktiengesellschaft |
Substituted 2,3-benzodiazepines derivatives
|
|
WO2021237100A1
(en)
|
2020-05-21 |
2021-11-25 |
Codiak Biosciences, Inc. |
Methods of targeting extracellular vesicles to lung
|
|
CN111592535B
(zh)
*
|
2020-06-22 |
2021-07-20 |
通化师范学院 |
一种抗egfr突变的抑制剂eai045的制备方法
|
|
US11839659B2
(en)
|
2020-07-02 |
2023-12-12 |
Northwestern University |
Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein
|
|
CN114057770B
(zh)
*
|
2020-08-06 |
2023-05-02 |
成都先导药物开发股份有限公司 |
靶向egfr蛋白降解的双功能化合物
|
|
EP4204418A1
(en)
|
2020-08-28 |
2023-07-05 |
Arvinas Operations, Inc. |
Rapidly accelerating fibrosarcoma protein degrading compounds and associated methods of use
|
|
AU2021342287A1
(en)
|
2020-09-14 |
2023-04-13 |
Arvinas Operations, Inc. |
Crystalline forms of a compound for the targeted degradation of estrogen receptor
|
|
US20240241020A1
(en)
|
2020-09-23 |
2024-07-18 |
Lonza Sales Ag |
Process for preparing extracellular vesicles
|
|
CN112608302B
(zh)
*
|
2020-12-28 |
2022-05-24 |
郑州大学第一附属医院 |
低氧还原激活靶向泛素化降解egfr蛋白的喹唑啉类衍生物及其应用
|
|
EP4291193A4
(en)
|
2021-02-10 |
2025-05-07 |
BeiGene Switzerland GmbH |
Egfr degraders and methods of use
|
|
CN113004251B
(zh)
*
|
2021-03-05 |
2022-09-27 |
郑州大学第一附属医院 |
含2-硝基咪唑的喹唑啉类衍生物及其应用
|
|
US20240197711A1
(en)
*
|
2021-04-02 |
2024-06-20 |
The Regents Of The University Of Michigan |
Combination Therapy for Cancer Treatment
|
|
CA3214806A1
(en)
|
2021-04-16 |
2022-10-20 |
Arvinas Operations, Inc. |
Modulators of bcl6 proteolysis and associated methods of use
|
|
US11981678B2
(en)
|
2021-04-29 |
2024-05-14 |
Northwestern University |
Substituted [1,2,4]triazolo[4,3-c]pyrimidin-5-amines and proteolysis-targeting chimeric derivatives thereof (PROTACs) that induce degradation of embryonic ectoderm development (EED) protein
|
|
US12042543B2
(en)
|
2021-04-30 |
2024-07-23 |
Northwestern University |
Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhancer zeste homolog 2 (EZH2) and proteolysis-targeting chimeric derivatives thereof (PROTACs) that induce degradation of EZH2
|
|
US20250129047A1
(en)
|
2021-07-04 |
2025-04-24 |
Newave Pharmaceutical Inc. |
Isoquinoline derivatives as mutant egfr modulators and uses thereof
|
|
WO2023034411A1
(en)
|
2021-09-01 |
2023-03-09 |
Oerth Bio Llc |
Compositions and methods for targeted degradation of proteins in a plant cell
|
|
CN115109055B
(zh)
*
|
2022-05-26 |
2023-11-28 |
北京康辰药业股份有限公司 |
一种用于egfr降解的双功能化合物及其应用
|
|
CN115160311B
(zh)
*
|
2022-05-26 |
2024-03-15 |
北京康辰药业股份有限公司 |
一种用于egfr降解的双功能化合物及其应用
|
|
WO2024050016A1
(en)
|
2022-08-31 |
2024-03-07 |
Oerth Bio Llc |
Compositions and methods for targeted inhibition and degradation of proteins in an insect cell
|
|
CN115286643B
(zh)
*
|
2022-09-02 |
2023-09-01 |
南京大学 |
蛋白质靶向降解化合物及其制备方法和应用
|
|
EP4584258A1
(en)
|
2022-09-07 |
2025-07-16 |
Arvinas Operations, Inc. |
Rapidly accelerated fibrosarcoma (raf) degrading compounds and associated methods of use
|
|
WO2024073507A1
(en)
|
2022-09-28 |
2024-04-04 |
Theseus Pharmaceuticals, Inc. |
Macrocyclic compounds and uses thereof
|
|
WO2024086132A1
(en)
*
|
2022-10-17 |
2024-04-25 |
Ohio University |
Protacs targeting viral enzymes for precise treatment of covid-19
|
|
CN121419983A
(zh)
|
2023-01-26 |
2026-01-27 |
阿尔维纳斯运营股份有限公司 |
基于小脑蛋白的kras降解protac及其相关用途
|
|
CN119317636A
(zh)
*
|
2023-03-07 |
2025-01-14 |
艾博生物科技(上海)有限公司 |
编码活化EGFR突变肽的免疫调节治疗性mRNA组合物
|
|
KR20260020383A
(ko)
|
2023-05-31 |
2026-02-11 |
비원 메디슨즈 아이 게엠베하 |
Egfr 키나제의 분해를 위한 화합물
|
|
EP4734989A2
(en)
*
|
2023-06-29 |
2026-05-06 |
Dana-Farber Cancer Institute, Inc. |
Synthesis and in vitro characterization of proteolysis targeting chimeras (protacs) for degradation of dna methyltransferase 1 (dnmt1)
|
|
WO2025049555A1
(en)
|
2023-08-31 |
2025-03-06 |
Oerth Bio Llc |
Compositions and methods for targeted inhibition and degradation of proteins in an insect cell
|
|
WO2025137613A1
(en)
*
|
2023-12-22 |
2025-06-26 |
Ganymede Oncology, Inc. |
Cycloalkylene nrf2 protein degraders
|
|
WO2025235298A1
(en)
*
|
2024-05-07 |
2025-11-13 |
Nikang Therapeutics, Inc. |
Bifunctional compounds containing thiazolyl derivatives for degrading certain cyclin-dependent kinase via ubiquitin proteasome pathway
|